Article Text

Download PDFPDF
Journal club summaries
What's hot that the other lot got
  1. Benjamin Soar
  1. Correspondence to Benjamin Soar, Respiratory Centre, Royal Cornwall Hospital, Truro, Cornwall TR1 3LJ, UK; bensoar{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Talc pleurodesis improves survival of patients with malignant pleural effusions

This Croatian retrospective case control study compared patients who had undergone talc pleurodesis with a control group of matched patients who were treated with serial thoracentesis.1 One hundred and seven patients with proven malignant pleural effusions (metastatic breast and lung cancer) were included. Fifty-six were treated with talc pleurodesis and a control group of 51 patients matched in age, sex and disease underwent serial thoracentesis. The overall and subgroup survival with different tumour types and different performance status (PS) 1, 2 and 3 were compared. Patients undergoing talc pleurodesis had a longer average survival interval (MS) than the patients who underwent thoracentesis (MS 21.5 and MS 9 weeks respectively, p<0.001). The best results were observed in those with PS 1 (MS 35.5 and MS 11 weeks) and PS 2 (MS 21 and MS 10 weeks). There was no difference in groups at PS 3. The authors conclude that patients treated with …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.